Cost-Minimization Analysis of Deep-Brain Stimulation Using National Database of Japanese Health Insurance Claims
Cost-Minimization Analysis of Deep-Brain Stimulation Using National Database of Japanese Health Insurance Claims
复制标题
DOI：
10.1111/ner.12782
复制
发表时间：
2018-08-01
期刊：
影响因子：
2.8
通讯作者：
Shiroiwa, Takeru
中科院分区：
文献类型：
--
作者：
Akazawa, Manabu;Konomura, Keiko;Shiroiwa, Takeru
目的：介绍一种新的充电式双通道脑深部刺激(DBS)系统，用于治疗帕金森病和其他运动障碍。然而，这种设备的临床价值仍然不清楚，因为它的成本很高。材料和方法：我们使用日本国家医疗保险索赔数据库进行了成本最小化分析。结果：尽管充电式DBS的价格高于非充电式DBS，但考虑到植入手术的相关费用、更换频率和并发症风险，我们观察到20年来总共节省了840万日元。结论：在本研究中，现实世界的证据表明，充电式双通道DBS是节省总医疗成本的合理选择。价格修订应考虑医疗器械的成本效益调查结果。
Objectives: A new rechargeable dual-channel deep brain stimulation (DBS) system has been introduced for the treatment of Parkinson's disease and other movement disorders. However, the clinical value of the device, which has a high cost, remains unclear.Materials and Methods: We conducted a cost-minimization analysis using a national database of health insurance claims in Japan. DBS-related costs were compared between rechargeable and non-rechargeable devices and estimated across a 20-year period.Results: Although the price of rechargeable DBS was higher than that of non-rechargeable DBS, we observed total cost-savings of 8.4 million yen across 20 years by considering costs related to implantation surgery, frequency of replacement, and risk of complications.Conclusions: In this study, real-world evidence indicated that rechargeable dual-channel DBS is a reasonable choice for saving total medical costs. Price revisions should consider cost-effectiveness findings for medical devices.